160 related articles for article (PubMed ID: 31257946)
1. Preparation, characterization, and pharmacodynamics of insulin-loaded fumaryl diketopiperazine microparticle dry powder inhalation.
Xia Y; Su Y; Wang Q; Yang C; Tang B; Zhang Y; Tu J; Shen Y
Drug Deliv; 2019 Dec; 26(1):650-660. PubMed ID: 31257946
[No Abstract] [Full Text] [Related]
2. Fumaryl Diketopiperazine Microspheres Platform Design for Protein Pulmonary Delivery in Diabetes Rats Model.
Shen Y; Lu M; Liu J; Tu J; Yin Y; Li W
J Biomed Nanotechnol; 2020 Aug; 16(8):1241-1253. PubMed ID: 33397554
[TBL] [Abstract][Full Text] [Related]
3. Insulin lung deposition and clearance following Technosphere® insulin inhalation powder administration.
Cassidy JP; Amin N; Marino M; Gotfried M; Meyer T; Sommerer K; Baughman RA
Pharm Res; 2011 Sep; 28(9):2157-64. PubMed ID: 21491144
[TBL] [Abstract][Full Text] [Related]
4. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery.
Bi R; Shao W; Wang Q; Zhang N
J Biomed Nanotechnol; 2009 Feb; 5(1):84-92. PubMed ID: 20055110
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of inhaled recombinant human insulin dry powders: pharmacokinetics, pharmacodynamics and 14-day inhalation.
He J; Zhang G; Zhang Q; Chen J; Zhang Y; An X; Wang P; Xie S; Fang F; Zheng J; Tang Y; Zhu J; Yu Y; Chen X; Lu Y
J Pharm Pharmacol; 2019 Feb; 71(2):176-184. PubMed ID: 30324757
[TBL] [Abstract][Full Text] [Related]
7. Fumaryl diketopiperazine based effervescent microparticles to escape macrophage phagocytosis for enhanced treatment of pneumonia via pulmonary delivery.
Wang Q; Shen Y; Mi G; He D; Zhang Y; Xiong Y; Webster TJ; Tu J
Biomaterials; 2020 Jan; 228():119575. PubMed ID: 31677394
[TBL] [Abstract][Full Text] [Related]
8. Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose.
Ung KT; Rao N; Weers JG; Huang D; Chan HK
Int J Pharm; 2016 Sep; 511(2):1070-9. PubMed ID: 27480399
[TBL] [Abstract][Full Text] [Related]
9. Formulation of insulin-loaded N-trimethyl chitosan microparticles with improved efficacy for inhalation by supercritical fluid assisted atomization.
Shen YB; Du Z; Tang C; Guan YX; Yao SJ
Int J Pharm; 2016 May; 505(1-2):223-33. PubMed ID: 27034000
[TBL] [Abstract][Full Text] [Related]
10. Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats.
Quarta E; Chierici V; Flammini L; Tognolini M; Barocelli E; Cantoni AM; Dujovny G; Ecenarro Probst S; Sonvico F; Colombo G; Rossi A; Bettini R; Colombo P; Buttini F
J Control Release; 2020 Jul; 323():412-420. PubMed ID: 32325175
[TBL] [Abstract][Full Text] [Related]
11. Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery.
Bi R; Shao W; Wang Q; Zhang N
J Drug Target; 2008 Nov; 16(9):639-48. PubMed ID: 18982512
[TBL] [Abstract][Full Text] [Related]
12. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
13. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
You Y; Zhao M; Liu G; Tang X
J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Hassanzadeh K; Mahdavi H; Koohsoltani M; Nokhodchi A
Biopharm Drug Dispos; 2010 Mar; 31(2-3):189-201. PubMed ID: 20238376
[TBL] [Abstract][Full Text] [Related]
15. Improvement of stability and absorbability of dry insulin powder for inhalation by powder-combination technique.
Todo H; Okamoto H; Iida K; Danjo K
Int J Pharm; 2004 Mar; 271(1-2):41-52. PubMed ID: 15129972
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of insulin dry powder for inhalation.
Mahesh Kumar T; Misra A
Drug Dev Ind Pharm; 2006 Jul; 32(6):677-86. PubMed ID: 16885123
[TBL] [Abstract][Full Text] [Related]
18. Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration.
Depreter F; Amighi K
Eur J Pharm Biopharm; 2010 Nov; 76(3):454-63. PubMed ID: 20797437
[TBL] [Abstract][Full Text] [Related]
19. Pure insulin highly respirable powders for inhalation.
Balducci AG; Cagnani S; Sonvico F; Rossi A; Barata P; Colombo G; Colombo P; Buttini F
Eur J Pharm Sci; 2014 Jan; 51():110-7. PubMed ID: 23981336
[TBL] [Abstract][Full Text] [Related]
20. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
Pai RV; Jain RR; Bannalikar AS; Menon MD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
